ClinicalTrials.gg
TerminatedNCT03039296EPCSIVUpdated Jan 18, 2022

EuroPainClinics® Study IV (Prospective Observational Study)

An observational study in Low Back Pain and Facet Joint Pain, sponsored by Europainclinics z.ú.. Terminated at 1 site in Slovakia. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-01-18.

Sponsored by Europainclinics z.ú. · Observational

How we know

Why this study was terminated
The low number of participants was enrolled in to the clinical trial

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
4
Ages
18 Years to 70 Years
Sex
All
01

Study summary

In this prospective observational trial the effect of the Endoscopic rhizotomy microinvasive therapy should be examined in (approximately 150) adult patients with low back pain positive for facet joint pain component.

Read the detailed description

Facet joint pain encompasses a significant portion of possible sources of pain in patients with vertebrogenic algic syndrome. A typical symptom is intermittent radiation of pain in the back and legs. The cause of this pain is irritation of the medial branch of the dorsal nerve root, which innervates a facet joint. Confirmation of the source of pain involves using a local anaesthetic to block the medial branches of several vertebral areas. If, through this test, the facet joints are determined to be the source of pain the patient's condition is indicated for radiofrequency ablation of the nerve branches.

EuroPainClinics® Study IV (EPCS IV) is a prospective observational comparative study that will use pain scales to analyse changes in the neurological status of nerves of patients who undergo the minimally invasive procedure: radiofrequency nerve ablation and cryoablation of the lumber facet joints.

The study aims to investigate documented clinical results of the neurological conditions of patients, to compare pain scales and the use of analgesics over a number of time periods: prior to the procedure, 6 weeks post-procedure, as well as 6 and 12 months post-procedure. The data will be subsequently statistically analysed.

02

Conditions studied

  • Low Back Pain
  • Facet Joint Pain

Browse trials for

Keywords

  • Low back pain
  • Facet joints
  • Endoscopic rhizotomy
03

In context

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

This study's enrollment of 4 is below the median of 100 across 484 observational studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Europainclinics z.ú. is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The study aims to investigate documented clinical results of the neurological conditions of patients, to compare pain scales and the use of analgesics over a number of time periods: prior to the procedure, 6 weeks post-procedure, as well as 6 and 12 months post-procedure. The data will be subsequently statistically analysed.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who undergo Endoscopic rhizotomy therapy

Exclusion criteria

Exclusion Criteria:

  • No
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
4 participants (actual)
Target follow-up
4 Years
Patient registry
Yes

Groups and cohorts

  • One side endoscopic rhizotomy

    Endoscopic rhizotomy will be provided only on one back side according pain

    Procedure: Endoscopic rhizotomy

  • Both sides endoscopic rhizotomy

    Endoscopic rhizotomy will be provided on both back sides according pain

    Procedure: Endoscopic rhizotomy

Interventions

  • ProcedureEndoscopic rhizotomy

    Endoscopic rhizotomy (facet joint denervation) is carried out through the insertion of an endoscope to the medial spinal nerve area with the help of mobile C-arm x-ray guidance. The tissue surrounding the medial nerves is endoscopically visualized and dissected with a sterile grasper to expose the nerve structure. Finally, a radiofrequency probe is used to ablate the problematic medial branch nerve under direct endoscopic control. The procedure is concluded with the removal of the endoscope and the small incision is closed with 1-2 skin sutures.

06

What researchers measure

Primary outcomes

  1. Pain as assessed by the Visual analogue scale

    All acquired information will be noted in to the special anonymous protocol

    Time frame: 4 years

Secondary outcomes

  1. Pain localization as assessed by note of radiating dermatome as neurologic examination

    All acquired information will be noted in to the special anonymous protocol

    Time frame: 4 years

  2. Pain progress as assessed by global pain scale

    All acquired information will be noted in to the special anonymous protocol

    Time frame: 4 years

  3. Changes in analgesics drugs consumption as assessed by equianalgesic dose ratios for opioids

    All acquired information will be noted in to the special anonymous protocol

    Time frame: 4 years

07

Study locations

1 site
  • Europainclinics
    Košice, 04011, Slovakia
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2017 to primary completion in Dec 2021, 58 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 30, 2017
First posted
Feb 1, 2017
StartActual
Feb 3, 2017
Primary completionActual
Dec 31, 2021
CompletionActual
Dec 31, 2021
Last update
Jan 18, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 18, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03039296
Lead sponsor
Europainclinics z.ú.
Responsible party
Sponsor
First posted
Feb 1, 2017
Start date
Feb 3, 2017
Primary completion
Dec 31, 2021
Completion
Dec 31, 2021
Last update
Jan 18, 2022

Study contacts

Ladislav Kočan, MD PhD
study director · europainclinicsstudy@gmail.com

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion